JASMINE KANAPPILLY: Open Payments
NPI 1932542016 · MOUNT PROSPECT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,657 in 87 payments from 20 companies in 2025. Trend: 2023 $2,791 · 2024 $7,730 · 2025 $3,657
Food & beverage: $3,101Travel & lodging: $555
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 16 | $1,461 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $284 |
| Amgen Inc. | 8 | $250 |
| Novo Nordisk Inc | 4 | $197 |
| PFIZER INC. | 9 | $192 |
| AstraZeneca Pharmaceuticals LP | 6 | $168 |
| Edwards Lifesciences Corporation | 1 | $161 |
| Biosense Webster, Inc. | 1 | $143 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Merck Sharp & Dohme LLC | 7 | $134 |
Products named: COBALT DR MRI SURESCAN, JARDIANCE, AFFERA MAPPING SYSTEM, REPATHA, PASCAL, CARTO 3, FARXIGA, LEQVIO.
Industry payments across IL — which companies pay providers there.
